206 related articles for article (PubMed ID: 11173048)
1. Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2-specific inhibitors.
Whelton A
Am J Med; 2001 Feb; 110 Suppl 3A():33S-42S. PubMed ID: 11173048
[No Abstract] [Full Text] [Related]
2. Prostaglandins and renal damage.
Navarro JF
J Am Soc Nephrol; 1996 Aug; 7(8):1245-6. PubMed ID: 8866420
[No Abstract] [Full Text] [Related]
3. Are cyclooxygenase-2-selective inhibitors safe for the kidneys?
Phan O; Meier P; Burnier M
Joint Bone Spine; 2003 Aug; 70(4):237-41. PubMed ID: 12951303
[No Abstract] [Full Text] [Related]
4. [Benefits and risks of cyclooxygenase-2-selective inhibitor nonsteroidal antiinflammatory drugs].
Vallano A; Llop R; Bosch M
Med Clin (Barc); 2002 Oct; 119(11):429-34. PubMed ID: 12381279
[No Abstract] [Full Text] [Related]
5. [Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents].
Chiolero A; Würzner G; Burnier M
Nephrologie; 2000; 21(8):425-30. PubMed ID: 11213386
[TBL] [Abstract][Full Text] [Related]
6. Renal effects of cyclooxygyenase-2-selective inhibitors.
Brater DC
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S15-20; discussion S21-3. PubMed ID: 11992745
[TBL] [Abstract][Full Text] [Related]
7. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs.
Perazella MA; Tray K
Am J Med; 2001 Jul; 111(1):64-7. PubMed ID: 11448662
[No Abstract] [Full Text] [Related]
8. Cardiovascular events and COX-2 inhibitors.
Grant KD
JAMA; 2001 Dec; 286(22):2809; author reply 2811-2. PubMed ID: 11735744
[No Abstract] [Full Text] [Related]
9. Cardiovascular events and COX-2 inhibitors.
White WB; Whelton A
JAMA; 2001 Dec; 286(22):2811-2. PubMed ID: 11735749
[No Abstract] [Full Text] [Related]
10. Cardiovascular events and COX-2 inhibitors.
Konstam MA; Demopoulos LA
JAMA; 2001 Dec; 286(22):2809; author reply 2811-2. PubMed ID: 11735743
[No Abstract] [Full Text] [Related]
11. Cardiovascular events and COX-2 inhibitors.
Minic M
JAMA; 2001 Dec; 286(22):2810; author reply 2811-2. PubMed ID: 11735746
[No Abstract] [Full Text] [Related]
12. Cardiovascular events and COX-2 inhibitors.
Haldey EJ; Pappagallo M
JAMA; 2001 Dec; 286(22):2809-10; author reply 2811-2. PubMed ID: 11735745
[No Abstract] [Full Text] [Related]
13. Cyclooxygenase-2 inhibitor treatment of older osteoarthritis patients.
Andersen SJ
Compr Ther; 2003; 29(4):215-23. PubMed ID: 14989043
[TBL] [Abstract][Full Text] [Related]
14. The coxibs, selective inhibitors of cyclooxygenase-2.
Nzerue CM
N Engl J Med; 2001 Dec; 345(23):1708-9. PubMed ID: 11759655
[No Abstract] [Full Text] [Related]
15. [New nonsteroidal antirheumatic drugs].
Forster A; Michel BA
Praxis (Bern 1994); 2000 May; 89(20):855-60. PubMed ID: 10865508
[No Abstract] [Full Text] [Related]
16. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
Galli G; Panzetta G
G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
[TBL] [Abstract][Full Text] [Related]
17. [A new class of nonsteroidal anti-inflammatory agents: COXIBs].
Costantino S
Clin Ter; 2003; 154(1):5-6. PubMed ID: 12854276
[No Abstract] [Full Text] [Related]
18. Cyclooxygenase-2 inhibitors in aspirin-sensitive asthma.
Passero M; Chowdhry S
Chest; 2003 Jun; 123(6):2155-6; author reply 2156. PubMed ID: 12796206
[No Abstract] [Full Text] [Related]
19. Cyclooxygenase-2 selective inhibitors and the kidney.
Breyer MD; Hao C; Qi Z
Curr Opin Crit Care; 2001 Dec; 7(6):393-400. PubMed ID: 11805541
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study.
Mamdani M; Juurlink DN; Kopp A; Naglie G; Austin PC; Laupacis A
BMJ; 2004 Jun; 328(7453):1415-6. PubMed ID: 15138157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
